with MEK. Upon Ras stimulation, Ksr localises MEK together with Erk to membrane-bound, activated Raf. Raf promotes phosphorylation of MEK, which in turn is required to activate Erk by phosphorylation (Figure 1) .
But what are the molecular mechanisms that determine the subcellular localisation of Ksr? Two papers from the Morrison lab, one published in Molecular Cell [5] and now one in this issue of Current Biology [3] , provide novel and exciting insights. In quiescent cells, Ksr becomes phosphorylated at two serine residues (Ser297 and Ser392) through the action of the Cdc25C-associated kinase C-TAK1 [5] . Both sites had previously been described as binding sites for 14-3-3 [6] . Treatment of cells with growth factors did not alter the binding or kinase activity of C-TAK1, but resulted in dephosphorylation of Ksr specifically at Ser392, thereby releasing 14-3-3 from this site. Ser297 and Ser392 flank the cysteine-rich C1 domain (CA3), which is essential for translocation and accumulation of Ksr at the membrane [7] . The model that emerged from these studies proposes that the release of 14-3-3 causes a conformational change, allowing the C1 domain of Ksr to contact with as yet unknown membrane-bound ligands.
Ory et al. [3] go one step further to unravel the mechanism that controls Ksr dephosphorylation. Using mass spectrometry, they identified the serine/threonine phosphatase PP2A as a component of the Ksr signaling complex in cell culture and in brain lysates from mice. The PP2A core enzyme is a dimer consisting of a catalytic subunit and a structural A subunit. Several distinct B subunits can associate with this core structure to regulate the enzymatic activity [8] . Strikingly, the comparative analysis between growth-factor-stimulated and unstimulated cells revealed that the catalytic subunit and the structural A subunit are bound to Ksr under both conditions whereas the association of the regulatory B subunit with Ksr was dependent on growth factor stimulation.
Although this story is exciting enough on its own, one of the surprises is that PP2A is also required to regulate Raf activity [ One major outstanding issue is also the spatio-temporal control of Raf-MEK-Erk signaling. The diverse cellular processes controlled by the Erk signaling cascade, such as proliferation and cell survival, might be dependent on localisation and activation of this cascade at distinct subcellular sites. Indeed, MP1 (MEK partner 1), a scaffold protein which binds specifically to MEK1 but not MEK2, localises via an additional adaptor protein to endosomes and is required for Erk activation at this site [19] . This raises the more general question of how many scaffold proteins exist for each of the distinct MAPK pathways. Because these proteins have no significant sequence homology, the analysis of MAPK protein complexes isolated from different subcellular compartments by proteomic approaches might help to solve this difficult question. 
